Development of hybrid nanosystems

Project summary

​

Liposomes are self-assembling lipid-based nanoparticles that enclose an aqueous core. An advantage of liposomes is versatility in terms of efficient loading of both hydrophilic and hydrophobic therapeutics. Liposomes represent the largest category of clinically approved nanoparticles, but they have simple surfaces that display limited biointerfacing properties. 

In recent years, extracellular vesicles (EVs) have captured considerable interest due to their involvement in multiple physiological and pathological processes. EVs are cell-released nanoparticles that display complex surfaces with organotropic features, making them attractive as drug delivery systems. However, EVs also display disadvantages, such as reduced drug loading efficiency compared to synthetic counterparts. 

In this project, a library of hybrid nanosystems with various liposome and EV components will be developed. The hybrid nanosystems will be characterized and assessed in terms of loading efficiency (therapeutic peptides) and organotropism.